Issue 11/2017
Content (25 Articles)
Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
W. J. Heinz, D. Buchheidt, M. Christopeit, M. von Lilienfeld-Toal, O. A. Cornely, H. Einsele, M. Karthaus, H. Link, R. Mahlberg, S. Neumann, H. Ostermann, O. Penack, M. Ruhnke, M. Sandherr, X. Schiel, J. J. Vehreschild, F. Weissinger, G. Maschmeyer
Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia
Yinjun Lou, Yafang Ma, Jianai Sun, Sansan Suo, Hongyan Tong, Wenbin Qian, Wenyuan Mai, Haitao Meng, Jie Jin
Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy
Sang-Bo Oh, Sung-Woo Park, Joo-Seop Chung, Won-Sik Lee, Ho-Seop Lee, Su-Hee Cho, Yoon-Suk Choi, Sung-Nam Lim, Ho-Jin Shin
A comparison of therapeutic dosages of decitabine in treating myelodysplastic syndrome: a meta-analysis
Bo Yang, Ruili Yu, Lili Cai, Xiaohua Chi, Cui Liu, Lei Yang, Xueyan Wang, Peifeng He, Xuechun Lu
Encouraging results with the compassionate use of hydralazine/valproate (TRANSKRIP™) as epigenetic treatment for myelodysplastic syndrome (MDS)
Myrna Candelaria, Sebastian Burgos, Mayra Ponce, Ramiro Espinoza, Alfonso Dueñas-Gonzalez
The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment
Natalia Lorenzana, Laura Francisca Avila, Sara Alonso, Enrique Colado, Teresa Bernal
A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation
Tomoko Sato, Takaaki Konuma, Yoriko Miwa, Nozomi Sugihara, Yukari Tsuru, Hatsuko Narita, Satomi Kiriyama, Seiko Kato, Maki Oiwa-Monna, Koji Kobayashi, Satoshi Takahashi, Arinobu Tojo
Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation
Jiaqian Qi, Jie Wang, Jia Chen, Jian Su, Yaqiong Tang, Xiaojin Wu, Xiao Ma, Feng Chen, Changgeng Ruan, X. Long Zheng, Depei Wu, Yue Han
Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study
Martin Kropff, Martin Vogel, Guido Bisping, Rudolf Schlag, Rudolf Weide, Wolfgang Knauf, Heinrich Fiechtner, Georgi Kojouharoff, Stephan Kremers, Wolfgang E. Berdel
Patients with primary breast and primary female genital tract diffuse large B cell lymphoma have a high frequency of MYD88 and CD79B mutations
Xin-xin Cao, Jian Li, Hao Cai, Wei Zhang, Ming-hui Duan, Dao-bin Zhou
Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores
Hyewon Lee, Yu Ri Kim, Soo-Jeong Kim, Yong Park, Hyeon-Seok Eom, Sung Yong Oh, Hyo Jung Kim, Hye Jin Kang, Won-Sik Lee, Joon Ho Moon, Young-Woong Won, Tae-Sung Kim, Jin Seok Kim
PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma
Young Wha Koh, Jae-Ho Han, Dok Hyun Yoon, Cheolwon Suh, Jooryung Huh
Uterine intravascular lymphoma as a cause of fever of unknown origin
Jérôme Hadjadj, Hubert Nielly, Eve Piekarski, Wendy Cuccuini, Bénedicte Deau-Fischer, Muriel Hourseau, Khadija Benali, Claire Fieschi, Marc Aletti, Thomas Papo, Eric Oksenhendler, Lionel Galicier, David Boutboul
Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly
A. Partanen, J. Valtola, A. Ropponen, K. Vasala, K. Penttilä, L. Ågren, M. Pyörälä, T. Nousiainen, T. Selander, P. Mäntymaa, J. Pelkonen, V. Varmavuo, E. Jantunen
Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia
Elias H. Atta, Carlos B. L. Lima, Danielle S. P. Dias, Diego V. Clé, Mariana M. Bonduel, Gabriela B. Sciuccati, Larissa A. Medeiros, Michel M. Oliveira, Marco A. Salvino, Marlene P. Garanito, Patricia B. Blum Fonseca, Sara Teresinha O. Saad, Rodrigo T. Calado, Phillip Scheinberg
Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients
Hiroyuki Tsuda, Takahiro Tsuji, Mayumi Tsuji, Hiroshi Yamasaki
Widening the spectrum of deletions and molecular mechanisms underlying alpha-thalassemia
José Ferrão, Marisa Silva, Lúcia Gonçalves, Susana Gomes, Pedro Loureiro, Andreia Coelho, Armandina Miranda, Filomena Seuanes, Ana Batalha Reis, Francisca Pina, Raquel Maia, Paula Kjöllerström, Estela Monteiro, João F. Lacerda, João Lavinha, João Gonçalves, Paula Faustino
Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT)
D. Maira, E. Cassinerio, A. Marcon, M. Mancarella, M. Fraquelli, P. Pedrotti, M. D. Cappellini
Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients
Philippos Klonizakis, Robert Klaassen, Nikolaos Sousos, Aris Liakos, Apostolos Tsapas, Efthymia Vlachaki
Effects of realgar (As4S4) on degradation of PML-RARA harboring acquired arsenic-resistance mutations
Mingshan Niu, Yangling Shen, Jialei Qi, Xuejiao Liu, Wei Sang, Qingyun Wu, Jiang Cao, Wei Chen, Yao Yao, Kailin Xu
Somatic mutations of calreticulin in patients with myelodysplastic/myeloproliferative neoplasms-unclassifiable
Xueya Zhang, Jingxin Pan
Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia
Alessandra Iurlo, Cristina Bucelli, Daniele Cattaneo, Nicola Orofino, Juri Alessandro Giannotta, Manuela Zappa, Umberto Gianelli, Agostino Cortelezzi
A novel heterozygous ALAS2 mutation in a female with macrocytic sideroblastic anemia resembling myelodysplastic syndrome with ring sideroblasts: a case report and literature review
Tohru Fujiwara, Noriko Fukuhara, Satoshi Ichikawa, Masahiro Kobayashi, Yoko Okitsu, Yasushi Onishi, Kazumichi Furuyama, Hideo Harigae
Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma
C. Phipps, K. W. Yeoh, Y. S. Lee, C. Nagarajan, S. Gopalakrishnan, L. P. Ho, W. Y. K. Hwang, Y. T. Goh, N. F. Grigoropoulos
Relative abundance of β-thalassemia-related mutations in southern China correlates with geographical coordinates
Yingying Zhao, Shenming Guan, Wenhui Song, Yongping Li, Lizhen Ling, Yu Wang, Xinshu Li, Lili Qin, Haijing Yu, Huanming Yang, Jian Wang, Jinlong Yang, Jin Liu, Le Cheng